TY  - JOUR 
AU  - Hernández-Boluda, Juan Carlos
AU  - Correa, Juan-Gonzalo
AU  - García-Delgado, Regina
AU  - Martínez López, Joaquín
AU  - Álvarez-Larrán, Alberto
AU  - Fox, María-Laura
AU  - García-Gutiérrez, Valentín
AU  - Pérez Encinas, Manuel Mateo
AU  - Ferrer-Marín, Francisca
AU  - Mata-Vázquez, María-Isabel
AU  - Raya, José-María
AU  - Estrada, Natalia
AU  - García, Silvia
AU  - Kerguelen, Ana
AU  - Durán, María-Antonia
AU  - Albors Ferreiro, Manuel
AU  - Cervantes, Francisco
PY  - 2017
UR  - http://hdl.handle.net/20.500.11940/22481
AB  - [EN] Objective: Erythropoiesis-stimulating agents (ESAs) are commonly used to treat the anemia of myelofibrosis (MF), but information on the predictors of response is limited.

Methods: Results of ESA therapy were analyzed in 163 MF patients with...
LA  - eng
KW  - Primary Myelofibrosis
KW  - Erythropoietin
KW  - Anemia
TI  - Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
DO  - 10.1111/ejh.12846
T2  - European Journal of Haematology
M2  - 407
KW  - CHUS
KW  - CHUO
VL  - 98
ER  -